James Hardie Industries stock tracks USD 125 million synergies

Published on 09/25/2026 at 07:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

James Hardie Industries stock stood at AUD 37.92 on September 24, 2026, after a 38.8 percent 12-month return. Annual organic growth targets reach 4 percent to 7 percent above market.

James Hardie, AU000000JHX1, Illustration mit AI erstellt.

James Hardie Industries stock (ISIN AU000000JHX1) stood at AUD 37.92 on the ASX on September 24, 2026, after a 38.8 percent 12-month return. The company is pairing that market performance with a cost and revenue synergy plan outlined at its September 15, 2026 Investor Day.

Synergies total USD 625 million

According to James Hardie on September 15, 2026, the company expects to achieve USD 125 million in cost synergies one year ahead of schedule. It also has USD 500 million in revenue synergies on track from the AZEK integration, putting the two stated synergy targets at USD 625 million.

The combination matters because the cost target is tied to an earlier delivery date, while the revenue target depends on selling across the enlarged product portfolio. James Hardie describes the opportunity as part of its plan to compound earnings and cash flow.

Growth target reaches 7 percent

The same Investor Day release sets annual organic growth at 4 percent to 7 percent above market. It links that target to a USD 23 billion North American material-conversion opportunity, self-help initiatives and the revenue synergies.

Management also reaffirmed second-quarter and fiscal 2027 sales and adjusted EBITDA guidance on September 15, 2026, while raising fiscal 2027 free cash flow guidance. The guidance excludes European operations pending the anticipated divestiture, so the figures describe the continuing business rather than the full historical portfolio.

Stock remains below its yearly high

James Hardie stock's AUD 37.92 level on September 24, 2026 compares with its 38.8 percent return over the prior 12 months. That comparison places the market valuation alongside the company's operational targets, with execution on the USD 125 million cost program serving as the nearer checkpoint.